Home/ Stocks/ NVO

Novo-Nordisk A/S

NVO XNYS

$36.89 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$163.52B

About Novo-Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Employees: 69.5K Website →

TickerDaily Coverage

Top Stocks Moving Pre-Market Today: NVDA, LLY, AMD Pre-Market Movers Before the Bell

Market News Sarah Mitchell · Mar 6, 2026

Several major stocks are posting outsized pre-market moves ahead of today's opening bell, driven by...

Why Is Allurion Technologies (ALUR) Stock Up 67.4% Today?

Penny Stocks Marcus Rivera · Feb 23, 2026

Allurion Technologies (ALUR) stock exploded 67.4% to $1.7901 on massive 125.3M-share...

View All Coverage →

Get NVO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Novo-Nordisk A/S.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.